NDC Compounded Drug 70092-663-43 Lidocaine Hydrochloride; Epinephrine
Solution Infiltration
Compounded Drug Product Information
NDC Crossover Products Matching Lidocaine Hydrochloride; Epinephrine
NDC crossover of Lido 1%-epi 10mcg/ml (buff) 3ml Nacl Syr with NDC 70092-663 a human compounded drug with other similar products matching the same substance name (Lidocaine Hydrochloride; Epinephrine) and the same administration route (infiltration) or dosage form (solution).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 70092-662-43 | Lido 0.5%-epi 10mcg/ml(buff)3ml Nacl Syr | Lido 0.5%-epi 10mcg/ml(buff)3ml Nacl Syr | 3 mL in 1 SYRINGE | Solution | Infiltration | Quva Pharma, Inc. |
Frequently Asked Questions
What is the NDC number assigned to Lido 0.5%-epi 10mcg/ml(buff)3ml Nacl Syr?
Lido 0.5%-epi 10mcg/ml(buff)3ml Nacl Syr was assigned by its manufacturer with NDC product code 70092-663. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Lido 0.5%-epi 10mcg/ml(buff)3ml Nacl Syr?
The NDC package code 70092-663-43 was assigned to a 3 mL in 1 SYRINGE of lidocaine hydrochloride; epinephrine administered infiltration via solution.
Who manufactures this product?
Lido 0.5%-epi 10mcg/ml(buff)3ml Nacl Syr is manufactured by an outsourced facility and labeled by Quva Pharma, Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 1 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by QuVa Pharma, Inc. with NDC product codes 70092-662-43.